482 results found

This is a summary of pharmaceutical patent cases in the report to assist in drafting pharmaceutical patent applications.

Throughout the pandemic, some pharmaceutical and health care products made false claims about the product's ability to prevent COVID-19 and improve immunity.

The Revisions would standardize the conduct of drug studies in China, as well as strengthen the management of such studies.

It appears nowadays clear that Chinese authorities are moving towards strict application of food safety provisions.

The opinions will create a level playground for R&D-focused drug and device companies, at home and abroad.

Recently, two bans concerning the animal testing of cosmetic products were introduced in the European Union ("EU"), the first being effective from 11 March 2009, and the second coming into effect from 11 March 2013.

The Chinese State Food and Drug Administration announced a plan for regulatory reform and is soliciting public comments through January 15, 2013.

Reflections focus on the topics of: response time; response attitude; internal PR teams and official press conferences.

The China Food and Drug Administration on May 12 proposed for the public's comments a draft regulation entitled Relevant Policies for Encouraging Innovations on Drugs and Medical Devices and Protecting Innovators' Rights and Interests ...

China's 2020 Amended Patent Law ("2020 Amendment") introduces a "Hatch-Waxman" like patent linkage system, which took effect on June 1, 2021.

The most recent amendment to the Chinese Patent Law describes the general principles of patent linkage, but lacks operational details.

A number of key South Korean food companies, including Samyang Food Co., CJ Cheiljedang Corp., Daesang Corp. and Ottogi Co., have formed a joint consultative body to file a lawsuit...

Starbucks Coffee Company and Boyu Capital, a private equity firm, have entered into an agreement in China, one of Starbucks' fastest-growing markets globally.

2024년 7월 4일, 중국 국가지식산권국(CNIPA) 션창위 국장은 베이징에서 외국인 투자기업(이하, 외자기업)의 지식재산권 보호에 관한 심포지엄을 주재함

On 24 April 2024, the European Commission (Commission) activated for the first time the International Procurement Instrument (IPI), opening an investigation into procurement

On July 17, 2013, after the investigation of GSK became public, the Chinese State Food and Drug Administration announced a six-month crackdown on misconduct in its drug market.

The draft is open for public comments until 25 November 2017.